Royalty Pharma plc
RPRX
Rankning i aktier
#849
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Aktiekurs
$63.17
Marknadsvärde
$28.13B
Förändring (1 dag)
1.64%
Förändring (1 år)
71.47%
Land
US
Handel Royalty Pharma plc (RPRX)
Kategori
Healthcare
Aktiekurshistorik för Royalty Pharma plc (RPRX)
Högsta slutkurs: $58.74 den 2026-10-01
Lägsta slutkurs: $49.50 den 2020-06-01
Lägsta slutkurs: $49.50 den 2020-06-01
Aktiekurshistorik för Royalty Pharma plc från 2020 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 27.38% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $45.98 | 36.92% |
SE
|
|
| $172.16 | 24.48% |
FR
|
|
| $59.52 | -0.48% |
IT
|
|
| $110.05 | 49.43% |
US
|
|
| $0.63 | -31.50% |
HK
|
